Vimarsana
Biggest News Aggregation in the World

Page 3 - Like Illness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Like Illness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Like Illness Today - Breaking & Trending Today

Ducey ends COVID-19 emergency declaration as Arizona prepares for future - Vimarsana News

Ducey ends COVID-19 emergency declaration as Arizona prepares for future

Governor Doug Ducey is terminating the state’s COVID-19 Declaration of Emergency as the virus is no longer as widespread as it once was. 

Governor Ducey Ends COVID-19 Emergency Declaration with Arizona Prepared for Future - Vimarsana News

Governor Ducey Ends COVID-19 Emergency Declaration with Arizona Prepared for Future

State, partners have implemented precautions and interventions to mitigate spreadPHOENIX — Governor Doug Ducey is terminating the state’s COVID-19 Declaration of Emergency based on the state reaching thresholds established by the Arizona Department of Health Services that show the virus is no longer as widespread as it once was. 

Covid Vaccine Spike Protein is a Pore-forming Toxin -- Health & Wellness -- Sott.net - Vimarsana News

Covid Vaccine Spike Protein is a Pore-forming Toxin -- Health & Wellness -- Sott.net

The spike protein pokes holes in cell membranes at concentrations much lower than those achieved with vaccination, contributing to COVID-like illness and mitochondrial damage. But is the J&J immune?

Source: sott.net
Yes, You Still Need a Booster After Being Infected with Omicron - Vimarsana News

Yes, You Still Need a Booster After Being Infected with Omicron

While timelines vary, everyone agrees that vaccinations only help reduce your chances of infection.

Source: snopes.com
Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants - Vimarsana News

Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants

A new study combines real-time syndromic surveillance data from daily cross-sectional surveys with a COVID-like illness (CLI) prevalence-based vaccine efficacy estimator to better explain the early onset of the omicron variant.